News & Updates
Showing Infectious Diseases articles
Showing
Show Multimedia Only

Updated EPIC-HR data bolster nirmatrelvir/ritonavir role against COVID-19
16 May 2025
byAudrey Abella
Updated data from the EPIC-HR* trial show reduced duration of COVID-19 symptoms and utilization of healthcare resources with nirmatrelvir/ritonavir (NMV/r) in high-risk, unvaccinated, nonhospitalized, symptomatic adults with COVID-19.
16 May 2025

Life quality poorer in COVID-19 survivors with ongoing symptoms
13 May 2025
byStephen Padilla
In adults who have survived the COVID-19 pandemic, health-related quality of life (HRQoL) is high among those who had either recovered from post-COVID-19 condition (PCC) or had never been afflicted with PCC, according to a study.
13 May 2025

Monoclonal antibodies vs COVID-19 up risks of hepatotoxicity, neutropenia
08 May 2025
byStephen Padilla
Treatment with monoclonal antibodies (mAbs) among COVID-19 patients is associated with a higher risk of hepatotoxicity and neutropenia when compared with standard of care (SoC) or placebo, reports a study.
08 May 2025






